264 related articles for article (PubMed ID: 24632331)
1. Synergistic apoptotic effect of Doxil ® and aminolevulinic acid-based photodynamic therapy on human breast adenocarcinoma cells.
Zakaria S; Gamal-Eldeen AM; El-Daly SM; Saleh S
Photodiagnosis Photodyn Ther; 2014 Jun; 11(2):227-38. PubMed ID: 24632331
[TBL] [Abstract][Full Text] [Related]
2. The enhanced anti-cancer effect of hexenyl ester of 5-aminolaevulinic acid photodynamic therapy in adriamycin-resistant compared to non-resistant breast cancer cells.
Yoon JH; Yoon HE; Kim O; Kim SK; Ahn SG; Kang KW
Lasers Surg Med; 2012 Jan; 44(1):76-86. PubMed ID: 22246987
[TBL] [Abstract][Full Text] [Related]
3. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
4. 5-aminolevulinic acid-mediated photodynamic therapy on Hep-2 and MCF-7c3 cells.
Alvarez MG; Lacelli MS; Rivarola V; Batlle A; Fukuda H
J Environ Pathol Toxicol Oncol; 2007; 26(2):75-82. PubMed ID: 17725533
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy using 5-aminolevulinic acid triggered DNA damage of adenocarcinoma breast cancer and hepatocellular carcinoma cell lines.
Abo-Zeid MAM; Abo-Elfadl MT; Mostafa SM
Photodiagnosis Photodyn Ther; 2018 Mar; 21():351-356. PubMed ID: 29355735
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
7. Low-dose arsenic trioxide enhances 5-aminolevulinic acid-induced PpIX accumulation and efficacy of photodynamic therapy in human glioma.
Wang C; Chen X; Wu J; Liu H; Ji Z; Shi H; Gao C; Han D; Wang L; Liu Y; Yang G; Fu C; Li H; Zhang D; Liu Z; Li X; Yin F; Zhao S
J Photochem Photobiol B; 2013 Oct; 127():61-7. PubMed ID: 23962849
[TBL] [Abstract][Full Text] [Related]
8. Access to a novel near-infrared photodynamic therapy through the combined use of 5-aminolevulinic acid and lanthanide nanoparticles.
Shimoyama A; Watase H; Liu Y; Ogura S; Hagiya Y; Takahashi K; Inoue K; Tanaka T; Murayama Y; Otsuji E; Ohkubo A; Yuasa H
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):607-14. PubMed ID: 24284118
[TBL] [Abstract][Full Text] [Related]
9. Effect of 5-aminolevulinic acid-mediated photodynamic therapy on MCF-7 and MCF-7/ADR cells.
Tsai T; Hong RL; Tsai JC; Lou PJ; Ling IF; Chen CT
Lasers Surg Med; 2004; 34(1):62-72. PubMed ID: 14755426
[TBL] [Abstract][Full Text] [Related]
10. Modulation of telomerase and signal transduction proteins by hexyl-ALA-photodynamic therapy (PDT) in human doxorubicin resistant cancer cell models.
Chu ES; Yow CM
Photodiagnosis Photodyn Ther; 2012 Sep; 9(3):243-55. PubMed ID: 22959804
[TBL] [Abstract][Full Text] [Related]
11. The natural flavonoid silybin improves the response to Photodynamic Therapy of bladder cancer cells.
Gándara L; Sandes E; Di Venosa G; Prack Mc Cormick B; Rodriguez L; Mamone L; Batlle A; Eiján AM; Casas A
J Photochem Photobiol B; 2014 Apr; 133():55-64. PubMed ID: 24705371
[TBL] [Abstract][Full Text] [Related]
12. Enhancing the efficiency of 5-aminolevulinic acid-mediated photodynamic therapy using 5-fluorouracil on human melanoma cells.
Tahmasebi H; Khoshgard K; Sazgarnia A; Mostafaie A; Eivazi MT
Photodiagnosis Photodyn Ther; 2016 Mar; 13():297-302. PubMed ID: 26321747
[TBL] [Abstract][Full Text] [Related]
13. ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy.
Palasuberniam P; Yang X; Kraus D; Jones P; Myers KA; Chen B
Sci Rep; 2015 Aug; 5():13298. PubMed ID: 26282350
[TBL] [Abstract][Full Text] [Related]
14. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
[TBL] [Abstract][Full Text] [Related]
15. Her2 oncogene transformation enhances 5-aminolevulinic acid-mediated protoporphyrin IX production and photodynamic therapy response.
Yang X; Palasuberniam P; Myers KA; Wang C; Chen B
Oncotarget; 2016 Sep; 7(36):57798-57810. PubMed ID: 27527860
[TBL] [Abstract][Full Text] [Related]
16. Hypericin and 5-aminolevulinic acid-induced protoporphyrin IX induce enhanced phototoxicity in human endometrial cancer cells with non-coherent white light.
Schneider-Yin X; Kurmanaviciene A; Roth M; Roos M; Fedier A; Minder EI; Walt H
Photodiagnosis Photodyn Ther; 2009 Mar; 6(1):12-8. PubMed ID: 19447367
[TBL] [Abstract][Full Text] [Related]
17. Optimization of 5-aminolevulinic acid-based photodynamic therapy protocol for breast cancer cells.
Guney Eskiler G; Deveci Ozkan A; Sozen Kucukkara E; Kamanlı AF; Gunoğlu B; Yıldız MZ
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101854. PubMed ID: 32512246
[TBL] [Abstract][Full Text] [Related]
18. Modulating ALA-PDT efficacy of mutlidrug resistant MCF-7 breast cancer cells using ALA prodrug.
Feuerstein T; Berkovitch-Luria G; Nudelman A; Rephaeli A; Malik Z
Photochem Photobiol Sci; 2011 Dec; 10(12):1926-33. PubMed ID: 22020364
[TBL] [Abstract][Full Text] [Related]
19. Etretinate enhances the susceptibility of human skin squamous cell carcinoma cells to 5-aminolaevulic acid-based photodynamic therapy.
Ishida N; Watanabe D; Akita Y; Nakano A; Yamashita N; Kuhara T; Yanagishita T; Takeo T; Tamada Y; Matsumoto Y
Clin Exp Dermatol; 2009 Apr; 34(3):385-9. PubMed ID: 19077103
[TBL] [Abstract][Full Text] [Related]
20. 5-Aminolevulinic Acid Enhances Ultrasound-mediated Antitumor Activity via Mitochondrial Oxidative Damage in Breast Cancer.
Shimamura Y; Tamatani D; Kuniyasu S; Mizuki Y; Suzuki T; Katsura H; Yamada H; Endo Y; Osaki T; Ishizuka M; Tanaka T; Yamanaka N; Kurahashi T; Uto Y
Anticancer Res; 2016 Jul; 36(7):3607-12. PubMed ID: 27354630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
